Related Experiment Video
Updated: Jan 27, 2026

Imaging Dendritic Spines of Rat Primary Hippocampal Neurons using Structured Illumination Microscopy
Published on: May 4, 2014
Reduced Hippocampal Dendrite Branching, Spine Density and Neurocognitive Function in Premature Rabbits, and Reversal
Damon Klebe1,2, Mahima Tibrewal3, Deep R Sharma1,2
1Department of Pediatrics, Albert Einstein College of Medicine, Bronx NY, USA.
Insights
Premature birth and lack of maternal care impair neurobehavioral function and brain development in preterm infants. Treatments with 17β-estradiol (E2) or 7,8-dihydroxyflavone (DHF) show potential to reverse these deficits.
Area of Science:
- Neuroscience
- Developmental Biology
- Pediatrics
Background:
- Preterm birth is associated with neurological and behavioral disorders.
- Non-maternal care in preterm infants may negatively impact neurodevelopment.
- The role of 17β-estradiol (E2) and TrkB agonists in mitigating these effects is under investigation.
Purpose of the Study:
- To investigate the impact of premature birth and non-maternal care on neurobehavioral function and hippocampal dendritic development.
- To assess the potential of E2 replacement or 7,8-dihydroxyflavone (DHF) to reverse these deficits in preterm newborns.
Main Methods:
- Comparison of preterm (E28.5) rabbit kits under non-maternal care with term-born controls.
- Neurobehavioral testing, assessment of hippocampal dendritic arborization and spine density.
- Analysis of CDC42, Rac1/2/3, and RhoA signaling pathways.
- Evaluation of E2 and DHF treatments on neurodevelopmental outcomes.
Main Results:
- Preterm birth and non-maternal care led to increased anxiety, poor social interaction, and reduced novelty preference.
- Reduced dendritic branching and spine density were observed in the CA1 hippocampus of preterm kits.
- E2 and DHF treatments reversed reduced spine density, normalized RhoA signaling, and improved cognitive function.
Conclusions:
- Prematurity and non-maternal care contribute to cognitive deficits and impaired hippocampal development.
- E2 replacement or DHF treatment may offer therapeutic potential for improving neurodevelopmental outcomes in premature infants.
Abstract:
Preterm-born children suffer from neurological and behavioral disorders. Herein, we hypothesized that premature birth and non-maternal care of preterm newborns might disrupt neurobehavioral function, hippocampal dendritic arborization, and dendritic spine density. Additionally, we assessed whether 17β-estradiol (E2) replacement or the TrkB receptor agonist, 7,8-dihydroxyflavone (DHF), would reverse compromised dendritic development and cognitive function in preterm newborns. These hypotheses were tested by comparing preterm (E28.5) rabbit kits cared and gavage-fed by laboratory personnel and term-kits reared and breast-fed by their mother doe at an equivalent postconceptional age. Neurobehavioral tests showed that both premature-birth and formula-feeding with non-maternal care led to increased anxiety behavior, poor social interaction, and lack of novelty preference compared with term-kits. Dendritic branching and number of total or mushroom dendritic spines were reduced in the CA1 field of preterm-kits compared with term controls. While CDC42 and Rac1/2/3 expression levels were lower, RhoA-activity was higher in preterm-kits compared with term controls. Both E2 and DHF treatment reversed prematurity-induced reduction in spine density, reduced total RhoA-GTPase levels, and enhanced cognitive function. Hence, prematurity and non-maternal care result in cognitive deficits, and reduced dendritic arbors and spines in CA1. E2 replacement or DHF treatment might reverse changes in dendritic spines and improve neurodevelopment in premature infants.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

